Reha Technology AG

Reha Technology AG specializes in rehabilitation systems for physical recovery. Their primary products include treadmill and elliptical gait rehabilitation systems, such as the G-EO System and G-EO, which assist lower-limb recovery through controlled movement. They also produce virtual-display rehabilitation systems with powered support, like the Armotion, designed for upper-limb rehabilitation. These devices incorporate interactive feedback to aid in assisted movement training.

Reha Technology AG is headquartered in the United States. The company’s location is relevant for understanding its regulatory jurisdiction and compliance framework, particularly for devices marketed in the US.

Reha Technology AG’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class II devices, which are subject to stricter controls due to their moderate risk profile in clinical or rehabilitative settings.

Reha Technology AG’s devices fall under Class II classification, which is typical for medical devices posing moderate risk. This classification requires compliance with specific regulatory controls, such as performance standards or post-market surveillance, to ensure safety and effectiveness in rehabilitation applications.